Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
GBP 501M - 501M
Notice Type:
Contract Notice
Published Date:
08 September 2017
Closing Date:
10 October 2017
Location(s):
UKF EAST MIDLANDS (ENGLAND) (UK UNITED KINGDOM)
UKG WEST MIDLANDS (ENGLAND) (UK UNITED KINGDOM)
UKH EAST OF ENGLAND (UK UNITED KINGDOM)
Description:

The supply of proprietary pharmaceuticals to participating Authorities in the NHS Region: Midlands and East.

Period of Framework: 1.3.2018 — 29.2.2020. With an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.



Products are listed in the ITO documents.

Each individual National Product Code (NPC) pack description in each of the regions (Midlands and East) is deemed to be a separate product for the application of the award criteria.

There is no restriction on the number of products that bidders can offer for, or be awarded.

The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England.

The framework may also be used by private sector contractors and agents working on behalf of the above.

Download full details as .pdf
The Buyer:
NHS Commissioning Board (Operating Under the Name of NHS England)
CPV Code(s):
33600000 - Pharmaceutical products